Next Article in Journal
Folate Functionalized Lipid Nanoparticles for Targeted Therapy of Methicillin-Resistant Staphylococcus aureus
Next Article in Special Issue
Hybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy
Previous Article in Journal
Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer
Previous Article in Special Issue
New Prospects in Neutering Male Animals Using Magnetic Nanoparticle Hyperthermia
 
 
Review

Medical Applications of Metallic Bismuth Nanoparticles

1
Laboratoire de Génomique, Bioinformatique et Chimie Moléculaire (EA 7528), Equipe Chimie Moléculaire, Conservatoire National des Arts et Métiers (CNAM), HESAM Université, 2 Rue Conté, 75003 Paris, France
2
Service de Chimie Générale, Organique et Biomédicale, Laboratoire de RMN et d’Imagerie Moléculaire, Université de Mons, 19 Avenue Maistriau, B-7000 Mons, Belgium
*
Author to whom correspondence should be addressed.
Academic Editors: Lionel Fernel Gamarra, Alexandre Malta Rossi, Joao Paulo Borges and Javier Bustamante Mamani
Pharmaceutics 2021, 13(11), 1793; https://doi.org/10.3390/pharmaceutics13111793
Received: 28 September 2021 / Revised: 19 October 2021 / Accepted: 20 October 2021 / Published: 26 October 2021
(This article belongs to the Special Issue Magnetic Nanoparticles for Therapy and Diagnosis in Nanomedicine)
Recent reviews described the efficient syntheses of metallic bismuth nanoparticles. Nevertheless, few studies have been published on the medical applications of these nanoparticles compared to the number of studies on the well-documented clinical use of the bismuth(III) complex. An analysis of the literature revealed the significant potential of metallic bismuth nanoparticles in different theranostic applications. In the diagnostic field, preclinical proofs of concept have been demonstrated for X-ray, photoacoustic and fluorescence imaging. In the therapeutic field, several preclinical studies have shown the potential of bismuth nanoparticles as X-ray radiosensitizers for use in radiotherapy and as photothermal agents for applications in near infrared phototherapy. The properties of these metallic bismuth nanoparticles as bactericidal, fungicidal, antiparasitic and antibiofilm agents have also been studied. Although information concerning the toxic effects of these nanoparticles has been collected, these data are insufficient when considering the immediate clinical use of these new nanoparticles. View Full-Text
Keywords: bismuth; nanoparticles; theranostic agents; biocompatibility bismuth; nanoparticles; theranostic agents; biocompatibility
Show Figures

Graphical abstract

MDPI and ACS Style

Gomez, C.; Hallot, G.; Laurent, S.; Port, M. Medical Applications of Metallic Bismuth Nanoparticles. Pharmaceutics 2021, 13, 1793. https://doi.org/10.3390/pharmaceutics13111793

AMA Style

Gomez C, Hallot G, Laurent S, Port M. Medical Applications of Metallic Bismuth Nanoparticles. Pharmaceutics. 2021; 13(11):1793. https://doi.org/10.3390/pharmaceutics13111793

Chicago/Turabian Style

Gomez, Catherine, Gauthier Hallot, Sophie Laurent, and Marc Port. 2021. "Medical Applications of Metallic Bismuth Nanoparticles" Pharmaceutics 13, no. 11: 1793. https://doi.org/10.3390/pharmaceutics13111793

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop